Pages that link to "Q24630685"
Jump to navigation
Jump to search
The following pages link to State of the science: an update on renal cell carcinoma (Q24630685):
Displaying 78 items.
- The potential of radiotherapy to enhance the efficacy of renal cell carcinoma therapy (Q26783291) (← links)
- The PI3K/AKT Pathway and Renal Cell Carcinoma (Q26800216) (← links)
- Activators of G protein signaling in the kidney (Q26824228) (← links)
- Metastatic renal cell carcinoma: update on epidemiology, genetics, and therapeutic modalities (Q26852437) (← links)
- The bigger the better: determining nephron size in kidney (Q27026016) (← links)
- Modification of the tumor microenvironment as a novel target of renal cell carcinoma therapeutics (Q28393614) (← links)
- Cadmium alters the formation of benzo[a]pyrene DNA adducts in the RPTEC/TERT1 human renal proximal tubule epithelial cell line (Q28654305) (← links)
- Expression of von Hippel-Lindau tumor suppressor protein (pVHL) characteristic of tongue cancer and proliferative lesions in tongue epithelium (Q33733536) (← links)
- Mammalian Target of Rapamycin Inhibitors Resistance Mechanisms in Clear Cell Renal Cell Carcinoma (Q34077263) (← links)
- Chromosome 3p loss of heterozygosity is associated with a unique metabolic network in clear cell renal carcinoma (Q34405226) (← links)
- Functional significance of erythropoietin in renal cell carcinoma. (Q34543726) (← links)
- DNA methylation profiling reveals novel diagnostic biomarkers in renal cell carcinoma. (Q34694198) (← links)
- Prognostic value of EZH2 expression and activity in renal cell carcinoma: a prospective study (Q35060552) (← links)
- Safety and activity of temsirolimus and bevacizumab in patients with advanced renal cell carcinoma previously treated with tyrosine kinase inhibitors: a phase 2 consortium study (Q35144490) (← links)
- mTOR inhibition induces compensatory, therapeutically targetable MEK activation in renal cell carcinoma (Q35236736) (← links)
- Specific genomic aberrations predict survival, but low mutation rate in cancer hot spots, in clear cell renal cell carcinoma (Q35606411) (← links)
- Randomized Open-Label Phase II Trial of Apitolisib (GDC-0980), a Novel Inhibitor of the PI3K/Mammalian Target of Rapamycin Pathway, Versus Everolimus in Patients With Metastatic Renal Cell Carcinoma (Q35948290) (← links)
- Inactivation of the tumor suppressor gene von Hippel-Lindau (VHL) in granulocytes contributes to development of liver hemangiomas in a mouse model (Q36161809) (← links)
- Rho-associated kinase 1 inhibition is synthetically lethal with von Hippel-Lindau deficiency in clear cell renal cell carcinoma (Q36191526) (← links)
- Local Control Rates of Metastatic Renal Cell Carcinoma (RCC) to Thoracic, Abdominal, and Soft Tissue Lesions Using Stereotactic Body Radiotherapy (SBRT). (Q36222951) (← links)
- High-throughput simultaneous screen and counterscreen identifies homoharringtonine as synthetic lethal with von Hippel-Lindau loss in renal cell carcinoma (Q36231927) (← links)
- Oncogenic MicroRNAs Characterization in Clear Cell Renal Cell Carcinoma (Q36404165) (← links)
- Local control rates of metastatic renal cell carcinoma (RCC) to the bone using stereotactic body radiation therapy: Is RCC truly radioresistant? (Q36445513) (← links)
- Suppression of mitochondrial respiration with auraptene inhibits the progression of renal cell carcinoma: involvement of HIF-1α degradation. (Q36545983) (← links)
- Essential role for SphK1/S1P signaling to regulate hypoxia-inducible factor 2α expression and activity in cancer (Q36748690) (← links)
- Stearoyl-CoA desaturase 1 is a novel molecular therapeutic target for clear cell renal cell carcinoma (Q36818377) (← links)
- Angiogenic and signalling proteins correlate with sensitivity to sequential treatment in renal cell cancer (Q37081930) (← links)
- Prognostic Value of Plasma and Urine Glycosaminoglycan Scores in Clear Cell Renal Cell Carcinoma (Q37433431) (← links)
- Racial difference in histologic subtype of renal cell carcinoma (Q37482609) (← links)
- Infiltrating macrophages increase RCC epithelial mesenchymal transition (EMT) and stem cell-like populations via AKT and mTOR signaling (Q37536932) (← links)
- Variation in chromatin accessibility in human kidney cancer links H3K36 methyltransferase loss with widespread RNA processing defects (Q37550216) (← links)
- Matrix-regulated integrin αvβ5 maintains α5β1-dependent desmoplastic traits prognostic of neoplastic recurrence. (Q37616743) (← links)
- Context-dependent role for chromatin remodeling component PBRM1/BAF180 in clear cell renal cell carcinoma. (Q37627446) (← links)
- Dot1l expression predicts adverse postoperative prognosis of patients with clear-cell renal cell carcinoma (Q37709012) (← links)
- RLIP76 Targeted Therapy for Kidney Cancer (Q37741408) (← links)
- Immunologic and clinical effects of targeting PD-1 in lung cancer (Q38201196) (← links)
- Radiotherapy for renal-cell carcinoma (Q38201568) (← links)
- An emerging understanding of long noncoding RNAs in kidney cancer (Q38210909) (← links)
- Resistance to anti-angiogenic agents: a brief review of mechanisms and consequences (Q38390060) (← links)
- Identification and validation of dysregulated metabolic pathways in metastatic renal cell carcinoma (Q38484441) (← links)
- Analysis of renal cancer cell lines from two major resources enables genomics-guided cell line selection. (Q38704070) (← links)
- Effects of the novel heat shock protein 90 inhibitor AUY922 in renal cell carcinoma ACHN and 786-O cells (Q38815491) (← links)
- Cancer-associated fibroblasts promote renal cell carcinoma progression (Q38917416) (← links)
- Autophagy mediates HIF2α degradation and suppresses renal tumorigenesis. (Q38977659) (← links)
- Functional genomics identifies novel genes essential for clear cell renal cell carcinoma tumor cell proliferation and migration. (Q38979602) (← links)
- Identifying novel targets in renal cell carcinoma: design and synthesis of affinity chromatography reagents (Q39037619) (← links)
- Metabolic Alterations in Cancer and Their Potential as Therapeutic Targets (Q39340415) (← links)
- RBP2 induces stem-like cancer cells by promoting EMT and is a prognostic marker for renal cell carcinoma (Q39696157) (← links)
- SUSD2 is frequently downregulated and functions as a tumor suppressor in RCC and lung cancer (Q40056040) (← links)
- Integrating cytokines and angiogenic factors and tumour bulk with selected clinical criteria improves determination of prognosis in advanced renal cell carcinoma (Q40132819) (← links)
- Addressing metabolic heterogeneity in clear cell renal cell carcinoma with quantitative Dixon MRI. (Q41252294) (← links)
- Analysis of long non-coding RNA expression profiles in clear cell renal cell carcinoma (Q41611254) (← links)
- The apoptosis repressor with a CARD domain (ARC) gene is a direct hypoxia-inducible factor 1 target gene and promotes survival and proliferation of VHL-deficient renal cancer cells (Q41908755) (← links)
- PBRM1 and VHL expression correlate in human clear cell renal cell carcinoma with differential association with patient's overall survival (Q47370222) (← links)
- Extracellular vesicles isolated from human renal cell carcinoma tissues disrupt vascular endothelial cell morphology via azurocidin. (Q47702301) (← links)
- MiR-200c-3p inhibits cell migration and invasion of clear cell renal cell carcinoma via regulating SLC6A1. (Q49374135) (← links)
- MicroRNAs in clear cell renal cell carcinoma: biological functions and applications. (Q51158837) (← links)
- Gramicidin A: A New Mission for an Old Antibiotic. (Q51158842) (← links)
- Acetyl-CoA synthetase 2 enhances tumorigenesis and is indicative of a poor prognosis for patients with renal cell carcinoma. (Q52675092) (← links)
- [Novel biomarkers in renal cell carcinoma. Identification and functional characterization]. (Q53348060) (← links)
- RSUME inhibits VHL and regulates its tumor suppressor function. (Q53670511) (← links)
- Tissue Expression of Erythropoietin Predicts Survival Rates in Clear Cell Renal Cell Carcinoma (Q58585040) (← links)
- The Association Between Ascorbate and the Hypoxia-Inducible Factors in Human Renal Cell Carcinoma Requires a Functional Von Hippel-Lindau Protein (Q59798803) (← links)
- loss sensitizes cells to PI3Kβ and AKT inhibition (Q61813696) (← links)
- Methylation Signature for Prediction of Progression Free Survival in Surgically Treated Clear Cell Renal Cell Carcinoma (Q64058312) (← links)
- von Hippel-Lindau mutants in renal cell carcinoma are regulated by increased expression of RSUME (Q64074421) (← links)
- Genomic Alterations of Renal Cell Carcinoma and Clinical Implications in the Chinese Population (Q64099283) (← links)
- Renal cell carcinoma (Q85939114) (← links)
- The Role of DNA Methylation in Renal Cell Carcinoma (Q88733594) (← links)
- Identification of genes of prognostic value in the ccRCC microenvironment from TCGA database (Q89507779) (← links)
- Radiogenomics in Clear Cell Renal Cell Carcinoma: Correlations Between Advanced CT Imaging (Texture Analysis) and MicroRNAs Expression (Q90350181) (← links)
- Cancer du rein : tendances et perspectives (Q90811552) (← links)
- Cancer du rein et radiothérapie : radiorésistance et au-delà (Q90811601) (← links)
- Combination with Stereotactic Body Radiotherapy Offers a Promising Strategy to Overcome Resistance to Immunotherapy in Advanced Renal Cell Cancer (Q92219253) (← links)
- Lamin-B1 is a senescence-associated biomarker in clear-cell renal cell carcinoma (Q92557200) (← links)
- Prognostic value of downregulated 5-hydroxymethylcytosine expression in renal cell carcinoma: a 10 year follow-up retrospective study (Q92758082) (← links)
- The anti-apoptotic effect on cancer-associated fibroblasts of B7-H3 molecule enhancing the cell invasion and metastasis in renal cancer (Q92861617) (← links)
- MMPs, tyrosine kinase signaling and extracellular matrix proteolysis in kidney cancer (Q96123488) (← links)